David Pirman
University of New Haven(US)Biohaven Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Metabolomics and Mass Spectrometry Studies, Mass Spectrometry Techniques and Applications, Cancer, Lipids, and Metabolism, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer(2017)214 cited
- → Quantitative MALDI Tandem Mass Spectrometric Imaging of Cocaine from Brain Tissue with a Deuterated Internal Standard(2012)179 cited
- → Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer(2022)154 cited
- → Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase(2019)148 cited
- → Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas(2019)92 cited
- → Quantitative Tandem Mass Spectrometric Imaging of Endogenous Acetyl-l-carnitine from Piglet Brain Tissue Using an Internal Standard(2011)86 cited
- → Identifying Tissue-Specific Signal Variation in MALDI Mass Spectrometric Imaging by Use of an Internal Standard(2012)80 cited
- → Targeting hepatic glutaminase activity to ameliorate hyperglycemia(2018)78 cited
- → A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition(2019)72 cited